Ketamine as an Adjunctive Therapy for Major Depression
Status:
Completed
Trial end date:
2018-09-21
Target enrollment:
Participant gender:
Summary
Randomised, controlled, parallel-group, pilot clinical trial of ketamine vs. midazolam as an
adjunctive therapy for depression. The main purpose of the pilot study is to assess trial
processes to help inform a future definitive trial.